Hemab Therapeutics (COAG) vs Nanobiotix S.A. (NBTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Hemab Therapeutics is the larger company by market cap ($1.36 billion vs $1.18 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COAG | NBTX |
|---|---|---|
| Share price | $29.03 | $23.27 |
| Market cap | $1.36B | $1.18B |
| 1-day change | +1.15% | -5.50% |
| YTD return | — | +6.49% |
| 1-year return | — | +17.41% |
| 5-year return | — | +92.04% |
| EPS (TTM) | $-4.33 | $-1.27 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $55.42 | $57.14 |
| 52-week low | $23.00 | $14.78 |
| Distance from 52-week high | -47.62% | -59.28% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +110.82% | +131.59% |
| Average volume | 453.97K | 148.97K |
| Shares outstanding | 46.71M | 50.92M |
| Employees | 59 | 100 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Hemab Therapeutics
COAG stock →Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 59 employees
About Nanobiotix S.A.
NBTX stock →Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
COAG vs NBTX FAQ
Which is bigger, Hemab Therapeutics or Nanobiotix S.A.?
Hemab Therapeutics (COAG) is larger, with a market capitalization of $1.36B compared with $1.18B for Nanobiotix S.A. (NBTX).
Are Hemab Therapeutics and Nanobiotix S.A. in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Biological Products (No Diagnostic Substances) for Hemab Therapeutics and Biotechnology: Pharmaceutical Preparations for Nanobiotix S.A..